- Details
- Ruchika Talwar hosts Daniel Sentana Lledo to discuss the concept of time toxicity in prostate cancer treatment. Time toxicity measures the amount of time patients spend in the healthcare system and how it impacts their survival time gained from therapies. The conversation explores how even simple clinic visits for lab work or imaging can take around two hours, with additional time spent on transpo...
|
- Details
- Ruchika Talwar speaks with Andrew Harris about findings from the AUA Census regarding gender-based workplace experiences in urology. The discussion explores significant disparities between male and female urologists, including differences in negative differential treatment, work-life balance, and barriers to professional success. Dr. Harris highlights concerning trends showing increased burnout ra...
|
- Details
- Ruchika Talwar speaks with Timothy Lyon about a Urology Practice publication examining hospital-at-home care for urologic patients. The discussion explores Mayo's Advanced Care at Home program, which has enrolled over 3,000 patients across their clinical sites, with approximately 10% being urologic cases. Dr. Lyon describes how the program delivers hospital-level care in patients' homes, including...
|
- Details
- Ruchika Talwar speaks with Bashir Al Hussein Al Awamlh about quality of life considerations in prostate cancer treatment decision-making. The discussion focuses on the importance of shared decision-making and findings from the CEASAR study, which examines quality of life outcomes across different treatment modalities including surgery, radiation, and active surveillance. Dr. Al Hussein highlights...
|
- Details
- Ruchika Talwar hosts Hiren Patel to discuss a multi-institutional study examining the impact of social deprivation on anterior urethral stricture recurrence after urethroplasty. Using the TURNS database of over 1,400 patients, the research reveals that higher social deprivation scores correlate with increased stricture recurrence rates and shorter recurrence-free intervals following surgery. The c...
|
- Details
- Daniel Lee discusses patient-facing costs for advanced prostate cancer treatment within the VA Health Care System. The conversation explores how recent legislation and VA programs, including the Cleland-Dole Act of 2022, have improved access to care through initiatives like the National Tele-Oncology Program and Precision Oncology Program. While the VA system offers significant advantages with low...
|
- Details
- Ruchika Talwar speaks with Adam Weiner about a study examining international variations in prostate cancer care quality metrics. Using data from the TrueNTH Global Registry spanning 10 countries and over 60,000 patients, Dr. Weiner reveals striking differences in how nations approach prostate cancer management. The study looks at four key quality metrics, including the use of surveillance for low-...
|
- Details
- Ruchika Talwar hosts Rohan Patel to discuss a primer on caring for sexual and gender minority (SGM) patients with genitourinary cancers. Dr. Patel unpacks key concepts like sex, gender identity, and sexual orientation, highlighting the unique challenges SGM patients face in healthcare. He outlines practical strategies for creating inclusive clinical environments, from using organ-based inventories...
|
- Details
- Ruchika Talwar hosts Kathy Huen to discuss her research on the accuracy of US News and World Report hospital rankings for urology. Dr. Huen discusses her study comparing the U.S. News methodology to electronic medical record data, revealing significant discrepancies in patient attribution and outcome measures. The research finds that U.S. News rankings often misidentify patients as being under uro...
|
- Details
- Ruchika Talwar interviews Brian Lane about a MUSIC collaborative study on same-day discharges for radical prostatectomy patients in Michigan. Dr. Lane discusses the study's findings, which show that only 2.8% of patients had same-day discharges between 2018 and 2022, despite efforts to increase uptake. The study demonstrates that same-day discharge is safe, with readmission rates comparable to one...
|
